ArticleInterdisciplinary sciences, computational life sciences2026
Interpretable Cancer Survival Prediction by Fusing Semantic Labelling of Cell Types and Whole Slide Images.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Survival prediction involves multiple factors, such as histopathological image data and omics data, making it a typical multimodal task. In this work, we introduce semantic annotations for genes in different cell types based on cell biology knowledge, enabling the model to achieve interpretability at the cellular level. Since these cell type annotations are derived from the unique sites of origin for each cancer type, they can be more closely aligned with morphological features in whole slide images (WSIs) and address the issue of genomic annotation ambiguity. We then propose a multimodal fusion model, SurvTransformer, with multi-layer attention to fuse cell type tags (CTTs) and WSIs for survival prediction. Finally, through attention and integrated gradient attribution, the model provides biologically meaningful interpretable analysis at three different levels: cell type, gene, and histopathology image. Comparative experiments show that SurvTransformer achieves the highest consistency index across four cancer datasets. The survival curves generated are also statistically significant. Ablation experiments show that SurvTransformer outperforms models based on different labeling methods and attention representations. In terms of interpretability, case studies validate the effectiveness of SurvTransformer at three levels: cell type, gene, and histopathological image.
Indexed as
Identifiers
41006935What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.